ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +1.3% · nuevas posiciones netas -3.7% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +6 | 1.07B | $270.16B | +9 | −2 |
| Q1 2026 | 179 | -3 | 1.05B | $227.15B | +2 | −6 |
| Q4 2025 | 181 | -3 | 1.14B | $259.75B | +1 | −3 |
| Q3 2025 | 27 | 0 | 673.15M | $155.83B | — | −1 |
| Q2 2025 | 25 | +2 | 519.81M | $96.45B | +2 | — |
| Q1 2025 | 20 | 0 | 175.76M | $36.80B | — | — |
| Q4 2024 | 20 | 0 | 178.61M | $31.72B | — | — |
| Q3 2024 | 19 | 0 | 95.00M | $18.73B | +1 | −1 |
| Q2 2024 | 19 | — | 90.79M | $15.55B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 177.75M | +0.2% | $41.16B | 0.6% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (pasivo) | 145.98M | -1.0% | $33.80B | 0.6% | ▼ Trim | 2 | SEC ↗ ×23 |
| 3 | JPMorgan Chase ✦ | 113.07M | — | $26.18B | 0.8% | n/c | 1 | SEC ↗ ×46 |
| 4 | State Street Global Advisors ✦ (pasivo) | 79.82M | -0.2% | $18.48B | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 41.65M | — | $9.64B | 0.6% | n/c | 1 | SEC ↗ ×23 |
| 6 | Geode Capital Management ✦ (pasivo) | 40.44M | +3.2% | $9.33B | 0.6% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Fidelity (FMR) ✦ | 21.04M | +0.2% | $4.87B | 0.3% | ▲ Add | 2 | SEC ↗ ×6 |
| 8 | Goldman Sachs Group ✦ | 13.40M | — | $3.10B | 0.4% | n/c | 1 | SEC ↗ ×6 |
| 9 | T. Rowe Price ✦ | 10.60M | +17.0% | $2.45B | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 10.54M | +457.4% | $2.44B | 0.4% | ▲ Add | 6 | SEC ↗ ×9 |
| 11 | Capital World Investors ✦ | 6.34M | -2.1% | $1.47B | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 3.11M | -4.5% | $719.03M | 0.6% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 2.02M | -17.6% | $466.72M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 1.84M | +14.0% | $427.14M | 0.7% | ▲ Add | 6 | SEC ↗ |
| 15 | Marshall Wace ✦ | 1.28M | -7.4% | $295.72M | 0.3% | ▼ Trim | 6 | SEC ↗ ×3 |
| 16 | D. E. Shaw & Co. ✦ | 1.12M | -27.4% | $259.13M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Renaissance Technologies ✦ | 928.07K | -52.7% | $214.89M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 926.84K | +55.0% | $209.65M | 0.1% | ▲ Add | 6 | SEC ↗ ×7 |
| 19 | Point72 Asset Management ✦ | 359.44K | +6799.1% | $83.23M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 275.85K | -2.7% | $63.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 260.69K | -56.4% | $60.36M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 184.69K | -41.7% | $42.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 163.18K | -36.2% | $37.78M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 48.47K | +31.8% | $11.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 15.27K | -3.1% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | Dodge & Cox ✦ | 10.47K | 0.0% | $2.42M | 0.0% | Held | 6 | SEC ↗ |
| 27 | Harris Associates (Oakmark) ✦ | 3.16K | 0.0% | $732,361 | 0.0% | Held | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Norges Bank | $4.29B | era 0.5% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 4,042 tenedores, 1.24B acciones, $260.03B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 32.71K acc. · $8.18M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología